HomeANRO • NYSE
add
Alto Neuroscience Inc
Previous close
$2.29
Day range
$2.29 - $2.46
Year range
$1.60 - $17.55
Market cap
64.30M USD
Avg Volume
274.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 15.68M | 8.97% |
Net income | -15.17M | -13.06% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -15.50M | -8.51% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 160.75M | -21.92% |
Total assets | 171.92M | -18.11% |
Total liabilities | 32.82M | 95.14% |
Total equity | 139.10M | — |
Shares outstanding | 27.07M | — |
Price to book | 0.45 | — |
Return on assets | -22.43% | — |
Return on capital | -23.47% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -15.17M | -13.06% |
Cash from operations | -16.56M | -50.74% |
Cash from investing | -24.00K | 89.29% |
Cash from financing | 9.13M | -93.22% |
Net change in cash | -7.48M | -106.06% |
Free cash flow | -12.47M | -130.68% |
About
Founded
2019
Website
Employees
76
